Latest News
-
Monoclonal antibody combination can save COVID-19 patients’ lives
An antibody combination reduces the number of deaths among patients hospitalised with severe COVID-19 when they are are unable to mount their own immune response, British researchers have announced. Read more
-
Serious privacy problems’ warning over mobile health apps
Thousands of free mobile health apps downloaded to smart devices have inadequate and inconsistent privacy practices, according to new analysis published today. Read more
-
Cold virus may limit COVID-19
Viruses which cause the common cold may protect against COVID-19, new research suggests. Read more
-
Needle phobia partly explains vaccine refusal
People with needle phobia are twice as likely to delay or refuse a COVID-19 vaccine as others, British researchers report today. Read more
-
New guidance on sports related concussion
A new consensus statement on sports-related concussion is outlining the best course of action and the factors linked to persisting symptoms. Read more
-
Could semaglutide protect people with type 2 diabetes?
A major new study will assess if a daily dose of semaglutide could help to prevent people with type 2 diabetes developing cardiovascular disease, it has been announced. Read more
-
Computer model can predict inherited heart diseases outcomes
A computer method can help to tailor treatments for patients with inherited heart disease, it was announced last night. Read more
-
How intense exercise increases MND risk
High performance athletics can increase the change of developing motor neurone disease for those who are genetically at risk, British researchers have found. Read more
-
Caution urged in Europe over summer easing
The World Health Organisation has urged caution as European countries seek to ease pandemic restrictions over the summer. Read more
-
Placenta tests highlight early complications
Levels of proteins in the placenta can be measured to predict later gestational diabetes and other pregnancy complications, new research has shown. Read more
